Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.

Tytuł:
Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.
Autorzy:
Rossignol J; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .; College of Medicine, Central Michigan University, Mount Pleasant, MI, 48859, USA. .
Fink KD; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .; Faculté des Science et des Techniques, Université de Nantes, 44300, Nantes, France. .; INSERM U1064, ITUN, 44093, Nantes, France. .
Crane AT; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Davis KK; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Bombard MC; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Clerc S; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Bavar AM; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Lowrance SA; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Song C; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Witte S; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .
Lescaudron L; Faculté des Science et des Techniques, Université de Nantes, 44300, Nantes, France. .; INSERM U791, Laboratoire d'Ingenierie Osteo-Articulaire et Dentaire (LIOAD), 44042, Nantes, France. .
Dunbar GL; Field Neurosciences Laboratory for Restorative Neurology, Brain Research and Integrative Neuroscience Center, Program in Neuroscience, 1280 East Campus Drive, HP Building Room 2336, Mount Pleasant, MI, 48859, USA. .; Field Neurosciences Institute, Saginaw, MI, 48604, USA. .
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2015 Feb 19; Vol. 6, pp. 9. Date of Electronic Publication: 2015 Feb 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Bone Marrow Cells/*cytology
Huntington Disease/*therapy
Mesenchymal Stem Cells/*cytology
Animals ; Behavior, Animal ; Brain/metabolism ; Brain/pathology ; Brain-Derived Neurotrophic Factor/genetics ; Brain-Derived Neurotrophic Factor/metabolism ; Cells, Cultured ; Disease Models, Animal ; Female ; Humans ; Huntingtin Protein ; Male ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Transgenic ; Motor Activity ; Nerve Growth Factor/genetics ; Nerve Growth Factor/metabolism ; Nerve Tissue Proteins/genetics ; Receptor, trkB/genetics ; Receptor, trkB/metabolism ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism
References:
Circulation. 2004 Mar 16;109(10):1292-8. (PMID: 14993122)
Neurol Res. 2008 Dec;30(10):1086-90. (PMID: 18768110)
J Neurosci. 2000 Jul 1;20(13):5115-23. (PMID: 10864968)
Neurobiol Dis. 2008 Jun;30(3):375-87. (PMID: 18424161)
Cancer Res. 2006 Nov 15;66(22):10849-54. (PMID: 17108121)
Stem Cell Res Ther. 2013;4(5):130. (PMID: 24456799)
Science. 2001 Jul 20;293(5529):493-8. (PMID: 11408619)
Methods Mol Biol. 2012;879:147-64. (PMID: 22610559)
Neurobiol Learn Mem. 2007 May;87(4):495-509. (PMID: 17240173)
Cell. 1996 Nov 1;87(3):493-506. (PMID: 8898202)
Anat Rec. 1991 Dec;231(4):482-97. (PMID: 1793176)
Stem Cells Transl Med. 2012 Apr;1(4):279-88. (PMID: 23197807)
PLoS One. 2010;5(2):e9347. (PMID: 20179764)
J Neurosci. 2009 Oct 28;29(43):13589-602. (PMID: 19864571)
Am J Physiol Regul Integr Comp Physiol. 2006 Oct;291(4):R880-4. (PMID: 16728464)
Lancet Neurol. 2006 Apr;5(4):303-9. (PMID: 16545746)
Stem Cells Dev. 2011 Aug;20(8):1337-47. (PMID: 21083430)
Int J Neurosci. 2003 Jul;113(7):945-56. (PMID: 12881187)
Trends Neurosci. 2000 Oct;23(10):450. (PMID: 11006459)
Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):574-7. (PMID: 17427191)
Behav Brain Res. 2010 Dec 25;214(2):193-200. (PMID: 20493905)
Stem Cells. 2008 Oct;26(10):2542-51. (PMID: 18635865)
J Tissue Eng Regen Med. 2016 Feb;10 (2):149-61. (PMID: 23576360)
Arch Med Res. 2008 Apr;39(3):265-76. (PMID: 18279698)
Cytotherapy. 2006;8(4):315-7. (PMID: 16923606)
Eur J Neurosci. 2005 Feb;21(4):855-70. (PMID: 15787692)
Brain Res Rev. 2011 Jun 24;67(1-2):252-9. (PMID: 21356243)
Behav Brain Res. 2011 Mar 1;217(2):369-78. (PMID: 21070819)
Behav Cogn Neurosci Rev. 2006 Jun;5(2):63-79. (PMID: 16801683)
Cell Prolif. 2012 Oct;45(5):430-7. (PMID: 22925502)
Neurol Res. 2010 Mar;32(2):166-72. (PMID: 19570323)
PLoS One. 2011;6(8):e22924. (PMID: 21850243)
Mol Med Rep. 2012 Nov;6(5):1183-9. (PMID: 22923041)
J Cell Mol Med. 2009 Aug;13(8B):2547-58. (PMID: 20141619)
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9345-50. (PMID: 16751280)
Mol Cell Neurosci. 2008 Mar;37(3):454-70. (PMID: 18083596)
PLoS One. 2013;8(4):e59438. (PMID: 23565152)
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18189-94. (PMID: 16326808)
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12483-8. (PMID: 19620721)
Pharmacol Res. 2005 Aug;52(2):133-9. (PMID: 15967378)
Acta Neuropathol. 2009 Mar;117(3):329-38. (PMID: 19057918)
Genes Brain Behav. 2013 Feb;12(1):108-24. (PMID: 23006318)
Stem Cells. 2006 Apr;24(4):1095-103. (PMID: 16282438)
Mol Cell Neurosci. 2008 Sep;39(1):1-7. (PMID: 18571429)
Neurol Res. 2011 Apr;33(3):331-7. (PMID: 21513650)
Neurology. 2007 Jun 12;68(24):2093-8. (PMID: 17562830)
Substance Nomenclature:
0 (Brain-Derived Neurotrophic Factor)
0 (HTT protein, human)
0 (Huntingtin Protein)
0 (Nerve Tissue Proteins)
0 (Tumor Necrosis Factor-alpha)
9061-61-4 (Nerve Growth Factor)
EC 2.7.10.1 (Receptor, trkB)
Entry Date(s):
Date Created: 20150515 Date Completed: 20160204 Latest Revision: 20181202
Update Code:
20240104
PubMed Central ID:
PMC4429666
DOI:
10.1186/scrt545
PMID:
25971780
Czasopismo naukowe
Introduction: Huntington's disease (HD) is an autosomal dominant disorder caused by an expanded CAG repeat (greater than 38) on the short arm of chromosome 4, resulting in loss and dysfunction of neurons in the neostriatum and cortex, leading to cognitive decline, motor dysfunction, and death, typically occurring 15 to 20 years after the onset of motor symptoms. Although an effective treatment for HD has remained elusive, current studies using transplants of bone-marrow-derived mesenchymal stem cells provides considerable promise. This study further investigates the efficacy of these transplants with a focus on comparing how passage number of these cells may affect subsequent efficacy following transplantation.
Methods: In this study, mesenchymal stem cells isolated from the bone-marrow of mice (BM MSCs), were labeled with Hoechst after low (3 to 8) or high (40 to 50) numbers of passages and then transplanted intrastriatally into 5-week-old R6/2 mice, which carries the N-terminal fragment of the human HD gene (145 to 155 repeats) and rapidly develops symptoms analogous to the human form of the disease.
Results: It was observed that the transplanted cells survived and the R6/2 mice displayed significant behavioral and morphological sparing compared to untreated R6/2 mice, with R6/2 mice receiving high passage BM MSCs displaying fewer deficits than those receiving low-passage BM MSCs. These beneficial effects are likely due to trophic support, as an increase in brain derived neurotrophic factor mRNA expression was observed in the striatum following transplantation of BM MSCs.
Conclusion: The results from this study demonstrate that BM MSCs hold significant therapeutic value for HD, and that the amount of time the cells are exposed to in vitro culture conditions can alter their efficacy.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies